In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation
- PMID: 21213393
- DOI: 10.1002/smll.201001459
In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation
Abstract
The in vivo biodistribution and urinary excretion of spherical mesoporous silica nanoparticles (MSNs) are evaluated by tail-vein injection in ICR mice, and the effects of the particle size and PEGylation are investigated. The results indicate that both MSNs and PEGylated MSNs of different particle sizes (80-360 nm) distribute mainly in the liver and spleen, a minority of them in the lungs, and a few in the kidney and heart. The PEGylated MSNs of smaller particle size escape more easily from capture by liver, spleen, and lung tissues, possess longer blood-circulation lifetime, and are more slowly biodegraded and correspondingly have a lower excreted amount of degradation products in the urine. Neither MSNs nor PEGylated MSNs cause tissue toxicity after 1 month in vivo.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.ACS Nano. 2011 Jul 26;5(7):5390-9. doi: 10.1021/nn200365a. Epub 2011 Jun 8. ACS Nano. 2011. PMID: 21634407
-
The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.Biomaterials. 2010 Feb;31(6):1085-92. doi: 10.1016/j.biomaterials.2009.10.046. Epub 2009 Oct 31. Biomaterials. 2010. PMID: 19880176
-
Size dependent cellular uptake, in vivo fate and light-heat conversion efficiency of gold nanoshells on silica nanorattles.Nanoscale. 2012 Jun 7;4(11):3523-9. doi: 10.1039/c2nr30396e. Epub 2012 May 3. Nanoscale. 2012. PMID: 22552611
-
Mesoporous silica nanoparticles in medicine--recent advances.Adv Drug Deliv Rev. 2013 May;65(5):689-702. doi: 10.1016/j.addr.2012.07.018. Epub 2012 Aug 18. Adv Drug Deliv Rev. 2013. PMID: 22921598 Review.
-
Synthesis of mesoporous silica nanoparticles.Chem Soc Rev. 2013 May 7;42(9):3862-75. doi: 10.1039/c3cs35405a. Epub 2013 Feb 12. Chem Soc Rev. 2013. PMID: 23403864 Review.
Cited by
-
Biocompatibility assessment of Si-based nano- and micro-particles.Adv Drug Deliv Rev. 2012 Dec;64(15):1800-19. doi: 10.1016/j.addr.2012.05.008. Epub 2012 May 22. Adv Drug Deliv Rev. 2012. PMID: 22634160 Free PMC article. Review.
-
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics.J Control Release. 2012 Oct 10;163(1):46-54. doi: 10.1016/j.jconrel.2012.05.046. Epub 2012 Jun 6. J Control Release. 2012. PMID: 22684119 Free PMC article.
-
Acid-Degradable Hydrogen-Generating Metal-Organic Framework for Overcoming Cancer Resistance/Metastasis and Off-Target Side Effects.Adv Sci (Weinh). 2022 Apr;9(10):e2101965. doi: 10.1002/advs.202101965. Epub 2022 Jan 31. Adv Sci (Weinh). 2022. PMID: 35098699 Free PMC article.
-
Upconversion superballs for programmable photoactivation of therapeutics.Nat Commun. 2019 Oct 8;10(1):4586. doi: 10.1038/s41467-019-12506-w. Nat Commun. 2019. PMID: 31594932 Free PMC article.
-
A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.Nanotheranostics. 2023 Jan 1;7(1):70-89. doi: 10.7150/ntno.77395. eCollection 2023. Nanotheranostics. 2023. PMID: 36593800 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources